231 related articles for article (PubMed ID: 16963208)
1. Release characteristics of anionic drug compounds from liquid crystalline gels III. Chemical and iontophoretic enhancement of delivery across non-rate-limiting membranes.
Fitzpatrick D; Corish J
Int J Pharm; 2006 Nov; 325(1-2):90-8. PubMed ID: 16963208
[TBL] [Abstract][Full Text] [Related]
2. Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
Fitzpatrick D; Corish J
Int J Pharm; 2006 Mar; 311(1-2):139-46. PubMed ID: 16426777
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
4. Release characteristics of anionic drug compounds from liquid crystalline gels I: Passive release across non-rate-limiting membranes.
Fitzpatrick D; Corish J
Int J Pharm; 2005 Sep; 301(1-2):226-36. PubMed ID: 16084043
[TBL] [Abstract][Full Text] [Related]
5. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
6. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
7. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
8. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
9. Determination of the in vivo bioavailability of iontophoretically delivered diclofenac using a methyl nicotinate skin inflammation assay.
Lambrecht R; Clarys P; Clijsen R; Barel AO
Skin Res Technol; 2006 Aug; 12(3):211-6. PubMed ID: 16827697
[TBL] [Abstract][Full Text] [Related]
10. Iontophoretic and chemical enhancement of drug delivery. Part I: across artificial membranes.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2003 May; 257(1-2):41-55. PubMed ID: 12711160
[TBL] [Abstract][Full Text] [Related]
11. The use of kinetic N-order model in description of active substance release from various drug forms. Part 2. Analysis of paracetamol and sodium diclofenac release from methylcellulose.
Marciniak DM; Dryś A; Pluta J; Kubis AA
Acta Pol Pharm; 2008; 65(1):107-18. PubMed ID: 18536182
[TBL] [Abstract][Full Text] [Related]
12. Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin.
Sebastiani P; Nicoli S; Santi P
Int J Pharm; 2005 Mar; 292(1-2):119-26. PubMed ID: 15725558
[TBL] [Abstract][Full Text] [Related]
13. Release study of diclofenac from new carbomer gels.
Bregni C; Chiappetta D; Faiden N; Carlucci A; García R; Pasquali R
Pak J Pharm Sci; 2008 Jan; 21(1):12-6. PubMed ID: 18166512
[TBL] [Abstract][Full Text] [Related]
14. Ion-exchange fibers and drugs: a novel device for the screening of iontophoretic systems.
Vuorio M; Murtomäki L; Hirvonen J; Kontturi K
J Control Release; 2004 Jul; 97(3):485-92. PubMed ID: 15212880
[TBL] [Abstract][Full Text] [Related]
15. The delivery of ketoprofen from a system containing ion-exchange fibers.
Yu L; Li S; Yuan Y; Dai Y; Liu H
Int J Pharm; 2006 Aug; 319(1-2):107-13. PubMed ID: 16701973
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin.
He N; Li SK; Suhonen TM; Warner KS; Higuchi WI
J Pharm Sci; 2003 Feb; 92(2):297-310. PubMed ID: 12532380
[TBL] [Abstract][Full Text] [Related]
17. Liposomes and skin: from drug delivery to model membranes.
El Maghraby GM; Barry BW; Williams AC
Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
[TBL] [Abstract][Full Text] [Related]
18. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
Bachhav YG; Heinrich A; Kalia YN
Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689
[TBL] [Abstract][Full Text] [Related]
19. AC electrokinetic platform for iontophoretic transdermal drug delivery.
Lvovich VF; Matthews E; Riga AT; Kaza L
J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
